Jaguar Health, Inc. (JAGX)
| Market Cap | 89.87M |
| Revenue (ttm) | 6.98M |
| Net Income (ttm) | -45.73M |
| Shares Out | 44.81M |
| EPS (ttm) | -1.46 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,161,735 |
| Open | 1.90 |
| Previous Close | 1.95 |
| Day's Range | 1.81 - 1.92 |
| 52-Week Range | 0.56 - 13.41 |
| Beta | 1.47 |
| Analysts | Strong Buy |
| Price Target | 14.00 (+673.5%) |
| Est. Earnings Date | Nov 12, 2021 |
About JAGX
Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. It operates through two reportable segments, Human Health and Animal Health. The company, through its subsidiary, Napo Pharmaceuticals, Inc., focuses on developing and commercializing proprietary plant-based human gastrointestinal pharmaceuticals from plants harvested responsibly from rainforest areas. It markets Mytesi, a crofelemer 125 mg delayed-rel...
Financial Performance
In 2020, Jaguar Health's revenue was $9.39 million, an increase of 62.51% compared to the previous year's $5.78 million. Losses were -$33.81 million, -12.27% less than in 2019.
Financial StatementsAnalyst Forecast
According to 2 analysts, the average rating for Jaguar Health stock is "Strong Buy." The 12-month stock price forecast is 14.00, which is an increase of 673.48% from the latest price.
News
Jaguar Health Provides Updates on Crofelemer and Lechlemer Development Pipeline as well as Merger of Napo EU S.p.A. a...
Dragon SPAC and Jaguar subsidiary Napo EU submit required notification to the Italian government in support of consummating the merger Results accepted for third-party, investigator-initiated Phase 2 HA...
Jaguar Health's Founder and CEO Lisa Conte to Be Honored with Pure Earth Impact Award
Award celebrates Ms. Conte's 30-year, unrelenting commitment to supporting Indigenous communities in the Amazon and responsibly harvesting and commercializing the first-ever plant-based oral medicine ap...
Jaguar Health Announces that Ladenburg Thalmann is Hosting R&D Showcase Webinar About Cancer Therapy-related Diarrhea...
Leading oncologists discuss importance of supportive care for cancer patients to address debilitating diarrhea resulting from cancer therapy Virtual event 1:00 PM to 2:10 PM Eastern Registration open no...
Jaguar Health Receives "Complete" Letter from FDA for Last of Four Major Technical Sections for the Company's Applica...
Jaguar planning for launch of Canalevia™ for CID in dogs this December Canalevia is the first and only oral plant-based prescription drug candidate for CID in dogs SAN FRANCISCO, CA / ACCESSWIRE / Septe...
REMINDER: Jaguar Health to Host Investor Webcast Monday, September 20th at 8:30 AM Eastern Time
Click here to register for webcast Jaguar kicks off educational awareness contest in honor of Indigenous Peoples' Day; Click here to enter SAN FRANCISCO, CA / ACCESSWIRE / September 16, 2021 / Jaguar He...
Orphan Drug Designation Application Submitted by Jaguar Health Subsidiary for Crofelemer for Short Bowel Syndrome wit...
The conditional marketing authorization pathway in Europe for crofelemer for this orphan disease is the initial focus of Napo EU under the license agreement between Napo EU and Napo Pharmaceuticals Jagu...
Jaguar Health Announces Closing of Private Placement Priced at a Premium to Market
Participating investors include Jaguar CEO and CFO, Dragon SPAC S.p.A. sponsor Josh Mailman, and plant-based pharmaceutical manufacturing pioneer Indena S.p.A.
3 Top Penny Stocks That You Need to Know About Right Now
As September turns bullish for penny stocks, which small-caps are on your watchlist? The post 3 Top Penny Stocks That You Need to Know About Right Now appeared first on Penny Stocks to Buy, Picks, News ...
JAGX Stock: What Is Going on With Jaguar Health Today?
Today, JAGX stock is surging higher on news of executive appointments, as well as the company's recent reverse stock split. The post JAGX Stock: What Is Going on With Jaguar Health Today?
Jaguar Health Appoints Karen Brunke, Ph.D. as Corporate and Business Development EVP and Chip Whitlow as Animal Healt...
Appointments represent Jaguar's focus on forging business development partnerships to advance crofelemer development and access and preparing for the expected near-term approval and commercialization of...
Hot Penny Stocks That Top Investors Are Watching Right Now
Why top penny stock investors are watching these hot small-caps right now The post Hot Penny Stocks That Top Investors Are Watching Right Now appeared first on Penny Stocks to Buy, Picks, News and Infor...
Jaguar Health Stock Is Trading Lower In Reaction To Reverse Stock Split
Jaguar Health Inc (NASDAQ: JAGX) will effect a reverse stock split of its issued and outstanding voting common stock at an exchange ratio of 1-for-3. The Company's Common Stock will begin trading on a s...
Jaguar Health, Inc. Announces 1-for-3 Reverse Stock Split
Reverse split approved by majority of common stock shareholders at December 2020 special meeting of stockholders Shares of Jaguar common stock to begin trading on split-adjusted basis on September 8, 20...
Jaguar Health Reports Voting Results from 2021 Annual Meeting of Stockholders
Proposals 1, 2, 4, 5 & 6 approved SAN FRANCISCO, CA / ACCESSWIRE / September 3, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced the voting results of the Company's M...
Jaguar Health Subsidiary Napo Pharmaceuticals Submits Late-Breaking Abstract for Consideration for Presentation at th...
Exploratory study evaluating effects of crofelemer on gut microbiome SAN FRANCISCO, CA / ACCESSWIRE / August 23, 2021 / Napo Pharmaceuticals, the wholly-owned subsidiary of Jaguar Health, Inc. (NASDAQ:J...
Best Biotech Penny Stocks to Buy Right Now? 3 to Watch Next Month
Biotech penny stocks are heating up right now, here's 3 for next month's watchlist The post Best Biotech Penny Stocks to Buy Right Now? 3 to Watch Next Month appeared first on Penny Stocks to Buy, Picks...
Jaguar Health Subsidiary Napo Pharmaceuticals Signs License Agreement with its Italian Subsidiary, Napo EU S.p.A., to...
Per the terms of the agreement, Napo Pharmaceuticals will receive an upfront payment of $10 million payable in two installments following the anticipated merger of Napo EU and Dragon SPAC S.p.A. and is ...
5 Penny Stocks To Buy According To Top Wall Street Analysts In 2021
Analysts say these are penny stocks to buy. Do you agree?
Jaguar Health Subsidiary Announces Completion of Additional Preclinical Study of Lechlemer (NP-300), the Company's Hu...
In support of planned Investigational New Drug application for lechlemer, Napo Pharmaceuticals, Jaguar's wholly owned subsidiary, received comprehensive animal toxicity preclinical services supported by...
Jaguar Health, Inc. Reports 2021 Second Quarter Financial Results
Second quarter 2021 Mytesi ® net and gross sales were approximately $0.4 million and approximately $4.9 million Company transitioning to primarily selling Mytesi directly through selected specialty phar...
Recap: Jaguar Health Q2 Earnings
Shares of Jaguar Health (NASDAQ:JAGX) moved higher by 1.5% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 77.27% year over year to ($0.10), which ...
Jaguar Health Announces Time Change for Friday, August 13th Investor Webcast to 8:00 AM Eastern Time
Registration link for webcast appears below Company plans to file Q2 2021 10-Q on August 13, 2021 SAN FRANCISCO, CA / ACCESSWIRE / August 10, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "C...
Jaguar Health to Host Investor Webcast Friday, August 13th at 8:30 AM Eastern Time Regarding Q2 2021 Financials & Bus...
Registration link for webcast appears below Company plans to file Q2 2021 10-Q on August 13, 2021 Jaguar kicks off educational awareness contest in honor of African Traditional Medicine Day SAN FRANCISC...
Jaguar Health Announces Adjournment of Annual Meeting of Stockholders Until Friday, September 3, 2021 and Encourages ...
Based on a preliminary review of votes cast, over 75% have voted in favor of Proposals 2, 3, 4 & 6 Meeting scheduled to reconvene September 3, 2021 at 8:30 AM Pacific Standard Time to provide time to re...
REMINDER FROM JAGUAR HEALTH: Innovators with Jane King Interview with Lisa Conte to Air During Jaguar Investor Webcas...
Registration link for webcast appears below SAN FRANCISCO, CA / ACCESSWIRE / July 28, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) issued a reminder today that an Innovators with Jane King interview of Lisa...